NCT04414046View on ClinicalTrials.gov

TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

PHASE2RecruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Primary Immune Deficiency DisordersMetabolic Disease
Interventions
BIOLOGICAL

Haploidentical Hematopoietic Cell Transplantation

TCR alpha beta T-cell and CD19 B-cell depleted haploidentical transplantation

Trial Locations (1)

33701

RECRUITING

Johns Hopkins All Children's Hospital, St. Petersburg

All Listed Sponsors
lead

Johns Hopkins All Children's Hospital

OTHER